Cargando…

Identification of Malignant Cell Populations Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer Using Single-Cell RNA Sequencing

SIMPLE SUMMARY: Ovarian cancer has a high recurrence rate (~75%), and tumor heterogeneity is associated with such tumor recurrence. However, it is still poorly understood in ovarian cancer. To reveal tumor heterogeneity, we performed single-cell RNA sequencing (RNA-seq) of serous ovarian cancer cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sumitani, Naoki, Ishida, Kyoso, Sawada, Kenjiro, Kimura, Tadashi, Kaneda, Yasufumi, Nimura, Keisuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331511/ https://www.ncbi.nlm.nih.gov/pubmed/35892844 http://dx.doi.org/10.3390/cancers14153580

Ejemplares similares

Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types
por: Kobayashi, Masaki, et al.
Publicado: (2018)

Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells
por: Miyamoto, Mayuko, et al.
Publicado: (2020)

Downregulation of miR-194-5p induces paclitaxel resistance in ovarian cancer cells by altering MDM2 expression
por: Nakamura, Koji, et al.
Publicado: (2019)

Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells
por: Yoshimura, Akihiko, et al.
Publicado: (2018)

Low Expression of RGS2 Promotes Poor Prognosis in High-Grade Serous Ovarian Cancer
por: Ihlow, Jana, et al.
Publicado: (2022)

Th2 cells infiltrating high-grade serous ovarian cancer: a feature that may account for the poor prognosis
por: Su, Hao, et al.
Publicado: (2023)

High expression of Tie-2 predicts poor prognosis in primary high grade serous ovarian cancer
por: Sopo, Minna, et al.
Publicado: (2020)

Lipid Droplet Accumulation Independently Predicts Poor Clinical Prognosis in High-Grade Serous Ovarian Carcinoma
por: Iwahashi, Naoyuki, et al.
Publicado: (2021)

Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer
por: Feng, Li-yuan, et al.
Publicado: (2021)

Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
por: Kobayashi, Masaki, et al.
Publicado: (2020)

CRISPR/Cas9-mediated gene knockout of NANOG and NANOGP8 decreases the malignant potential of prostate cancer cells
por: Kawamura, Norihiko, et al.
Publicado: (2015)

MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis
por: Zanotti, Laura, et al.
Publicado: (2017)

Stromal infiltrating mast cells identify immunoevasive subtype high-grade serous ovarian cancer with poor prognosis and inferior immunotherapeutic response
por: Cao, Kankan, et al.
Publicado: (2021)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

Low Expression of Circular RNA hsa_circ_0078607 Predicts Poor Prognosis in High-Grade Serous Ovarian Cancer
por: Zhang, Nan, et al.
Publicado: (2021)

Cell Origins of High-Grade Serous Ovarian Cancer
por: Kim, Jaeyeon, et al.
Publicado: (2018)

Overexpression of CUEDC2 Predicts Poor Prognosis in Ovarian Serous Carcinomas
por: Wang, Aichun, et al.
Publicado: (2015)

The Transcription Factors Tbx18 and Wt1 Control the Epicardial Epithelial-Mesenchymal Transition through Bi-Directional Regulation of Slug in Murine Primary Epicardial Cells
por: Takeichi, Makiko, et al.
Publicado: (2013)

Essential Role for miR-196a in Brown Adipogenesis of White Fat Progenitor Cells
por: Mori, Masaki, et al.
Publicado: (2012)

High expression of ENPP1 in high-grade serous ovarian carcinoma predicts poor prognosis and as a molecular therapy target
por: Wang, Hanzhi, et al.
Publicado: (2021)

The poor prognosis of sarcomatoid carcinoma arising from low grade serous ovarian cancer: A case report and review of the literature
por: Haight, Paulina, et al.
Publicado: (2021)

Proteomic Discovery of Biomarkers to Predict Prognosis of High-Grade Serous Ovarian Carcinoma
por: Kim, Se Ik, et al.
Publicado: (2020)

AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization
por: Azzalini, Eros, et al.
Publicado: (2022)

Identification of Prognosis Biomarkers for High-Grade Serous Ovarian Cancer Based on Stemness
por: Wang, Zhihang, et al.
Publicado: (2022)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma
por: Cui, Xuelian, et al.
Publicado: (2015)

Increased Expression of LYNX1 in Ovarian Serous Cystadenocarcinoma Predicts Poor Prognosis
por: Liu, Hui, et al.
Publicado: (2020)

Similar protein expression profiles of ovarian and endometrial high-grade serous carcinomas
por: Hiramatsu, Kosuke, et al.
Publicado: (2016)

DNA methyltransferase 3b preferentially associates with condensed chromatin
por: Kashiwagi, Katsunobu, et al.
Publicado: (2011)

Pathophysiological Role and Potential Therapeutic Exploitation of Exosomes in Ovarian Cancer
por: Shimizu, Aasa, et al.
Publicado: (2020)

Pure Primary Ovarian Squamous Cell Carcinoma Perforating the Rectum
por: Mimura, Kazuya, et al.
Publicado: (2017)

Evaluation of HPV16 E7 expression in head and neck carcinoma cell lines and clinical specimens
por: Kitamura, Koji, et al.
Publicado: (2020)

A simple method using CRISPR-Cas9 to knock-out genes in murine cancerous cell lines
por: Ishibashi, Airi, et al.
Publicado: (2020)

DNA barcoding and gene expression recording reveal the presence of cancer cells with unique properties during tumor progression
por: Umeki, Yuka, et al.
Publicado: (2022)

Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review
por: Kobayashi, Masaki, et al.
Publicado: (2017)

NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis
por: Saga, Kotaro, et al.
Publicado: (2019)

Author Correction: Evaluation of HPV16 E7 expression in head and neck carcinoma cell lines and clinical specimens
por: Kitamura, Koji, et al.
Publicado: (2021)

The Role of MicroRNAs in Ovarian Cancer
por: Kinose, Yasuto, et al.
Publicado: (2014)

Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer
por: Xu, Xia, et al.
Publicado: (2013)

Clinical relevance of circulating cell-free microRNAs in ovarian cancer
por: Nakamura, Koji, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_r6qis7rm1ppmntt79bo4oholru